Ozempic coming soon to India: What is it? Benefits, side effects and controversies
India’s drug controller, the Central Drugs Standard Control Organisation (CDSCO), approved Ozempic (semaglutide) on 26 September for use…
Potential dangers of GLP-1 medications
SOUTH BEND, IN (WSBT) — Weight-loss drugs have made headlines with famous names, like tennis superstar Serena Williams,…
Novo Nordisk’s diabetes and weight loss drug sales growth decelerates
Novo Nordisk saw sales growth for its diabetes and obesity care segment slow in the first half of…